HomeTRYP • CNSX
add
Tryp Therapeutics Inc
Previous close
$0.060
Year range
$0.010 - $0.11
Market cap
5.73M CAD
Avg Volume
87.26K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 18.30K | -98.37% |
Operating expense | 690.33K | -45.46% |
Net income | -805.30K | 63.58% |
Net profit margin | -4.40K | -2,134.79% |
Earnings per share | -0.01 | 0.00% |
EBITDA | -517.09K | 72.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.26M | 2,779.41% |
Total assets | 2.11M | -70.32% |
Total liabilities | 19.69M | 890.79% |
Total equity | -17.58M | — |
Shares outstanding | 289.26M | — |
Price to book | -1.00 | — |
Return on assets | -250.60% | — |
Return on capital | -74.49% | — |
Cash Flow
Net change in cash
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -805.30K | 63.58% |
Cash from operations | -6.91M | -775.88% |
Cash from investing | 347.95K | 554.22% |
Cash from financing | -772.36K | 32.09% |
Net change in cash | 482.38K | 130.51% |
Free cash flow | -333.42K | -13.26% |
About
Founded
2013
Headquarters
Website
Employees
50